M2巨噬细胞模拟金属有机框架纳米酶——可见光驱动的氢气生成技术用于葡萄膜炎治疗
M2 Macrophage-Mimetic Metal-Organic Framework Nanozyme With Visible-Light-Driven Hydrogen Evolution for Uveitis Therapy
Shundong Cai, Mengdie Li, Jingbin Zhuang, Jinfa Ye, Songyi Wang, Jinglei Zhang, Mingyou Zhang, Qixuan Dai, Yun Han, Min Su, Wei Li, Gang Liu, Chengchao Chu
Journal:Small
IF:11.8
DOI:10.1002/smll.75929
PMID:42801506
Published:2026-09-27
research field:光催化活性氧纳米医学炎症性疾病眼科学
Abstract
Uveitis poses a severe threat to vision and represents a critical clinical challenge. Conventional therapeutic approaches often exhibit limited efficacy in controlling disease progression and lack efficient mechanisms for managing localized oxidative stress. Given that molecular hydrogen (H 2 ) holds substantial promise for treating oxidative and inflammatory diseases via its selective antioxidant properties, we report a metal–organic framework (MOF) nanozyme-based hydrogen nanogenerator. This system integrates photocatalytic visible-light-triggered H 2 generation with multi-enzyme-like antioxidant functions for targeted uveitis management. The engineered Pt-embedded MOF nanozymes (Pt@MOF) concurrently catalyze hydrogen evolution under visible light and display superoxide dismutase- and catalase-like activities, achieving comprehensive scavenging of overproduced reactive oxygen species (ROS). Furthermore, camouflaging the nanozyme with M2 macrophage-derived cell membrane vesicles (CMVs) endows the nanoplatform with active inflammation-targeting ability, thereby enhancing the accumulation in inflamed ocular tissues. Following topical administration, this biomimetic nanomedicine successfully mitigates oxidative stress and suppresses pro-inflammatory cytokines both in vitro and in a rat model of acute uveitis. Overall, this study underscores the immense potential of integrating light-driven hydrogen therapy with nanozyme therapy, offering a highly effective strategy that could revolutionize future therapeutic interventions for inflammatory eye diseases.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


